Literature DB >> 21465310

Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema.

Jessica I Goldberg1, Elyn R Riedel, Monica Morrow, Kimberly J Van Zee.   

Abstract

BACKGROUND: Sentinel lymph node biopsy (SLNB) is associated with reduced morbidity, although lymphedema remains a significant complication. Previously, we found no association between number of excised lymph nodes (LNs) and measured lymphedema in SLNB patients. In this analysis, we examined the relationship between number of LNs excised during SLNB and patient-perceived lymphedema.
METHODS: A total of 600 women who underwent SLNB for breast cancer were prospectively studied. Measured lymphedema was evaluated by circumferential bilateral upper-extremity measurements taken preoperatively and 3-8 years postoperatively. Patient-perceived lymphedema was evaluated by interview at follow-up. The relationship between lymphedema, total LNs excised, and clinicopathologic variables was assessed with Fisher's exact test, Wilcoxon rank-sum test, kappa statistic, and McNemar's test.
RESULTS: At a median of 5 years, 18 (3%) patients reported perceived lymphedema. More LNs were excised in patients with perceived lymphedema compared with those without (median, 5.5 vs. 3; p = 0.01). Only 6 of 18 women with perceived lymphedema had objectively measured lymphedema (kappa = 0.22). Patients with numbness more likely reported perceived lymphedema (p = 0.03) and had more LNs excised (p = 0.02). Women with surgery on the nondominant axilla were less likely to perceive arm swelling, regardless of the presence of measured lymphedema.
CONCLUSIONS: After SLNB alone, patient-perceived lymphedema is uncommon, but its prevalence increases with more LNs excised. There is poor agreement between patient perceptions and objective measures. Our data suggest that factors other than limb enlargement, such as sensory nerve injury resulting from retrieval of more LNs and laterality of surgery, may play a significant role in patient perception of lymphedema after SLNB.

Entities:  

Mesh:

Year:  2011        PMID: 21465310     DOI: 10.1245/s10434-011-1688-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Silica-coated gold nanoplates as stable photoacoustic contrast agents for sentinel lymph node imaging.

Authors:  Geoffrey P Luke; Ashvin Bashyam; Kimberly A Homan; Suraj Makhija; Yun-Sheng Chen; Stanislav Y Emelianov
Journal:  Nanotechnology       Date:  2013-10-11       Impact factor: 3.874

2.  Label-free Detection of Lymph Node Metastases with US-guided Functional Photoacoustic Imaging.

Authors:  Geoffrey P Luke; Stanislav Y Emelianov
Journal:  Radiology       Date:  2015-05-21       Impact factor: 11.105

3.  The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients.

Authors:  Rachel K Voss; Kate D Cromwell; Yi-Ju Chiang; Jane M Armer; Merrick I Ross; Jeffrey E Lee; Jeffrey E Gershenwald; Bob R Stewart; Simona F Shaitelman; Janice N Cormier
Journal:  J Surg Oncol       Date:  2015-10-18       Impact factor: 3.454

4.  Long-term follow-up results of fluorescence and blue dye guided sentinel lymph node biopsy in early breast cancer.

Authors:  Chaobin Wang; Fuzhong Tong; Yingming Cao; Peng Liu; Bo Zhou; Hongjun Liu; Lin Cheng; Miao Liu; Jiajia Guo; Fei Xie; Houpu Yang; Siyuan Wang; Yuan Peng; Shu Wang
Journal:  Breast Cancer Res Treat       Date:  2021-03-24       Impact factor: 4.872

5.  Sensory signs and symptoms in women with self-reported breast cancer-related lymphedema: a case-control study close up.

Authors:  An De Groef; Nele Devoogdt; Ceren Gursen; Niamh Moloney; Victoria Warpy; Jolien Daelemans; Lore Dams; Vincent Haenen; Elien Van der Gucht; An-Kathleen Heroes; Tessa De Vrieze; Elizabeth Dylke
Journal:  J Cancer Surviv       Date:  2021-08-28       Impact factor: 4.062

6.  Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors.

Authors:  Geoffrey P Luke; Jeffrey N Myers; Stanislav Y Emelianov; Konstantin V Sokolov
Journal:  Cancer Res       Date:  2014-08-08       Impact factor: 12.701

7.  VEGF-C improves regeneration and lymphatic reconnection of transplanted autologous lymph node fragments: An animal model for secondary lymphedema treatment.

Authors:  Lia Schindewolffs; Gerhard Breves; Manuela Buettner; Catarina Hadamitzky; Reinhard Pabst
Journal:  Immun Inflamm Dis       Date:  2014-11-17

Review 8.  Lymphoedema After Breast Cancer Treatment is Associated With Higher Body Mass Index: A Systematic Review and Meta-Analysis.

Authors:  Astère Manirakiza; Laurent Irakoze; Lin Shui; Sébastien Manirakiza; Louis Ngendahayo
Journal:  East Afr Health Res J       Date:  2019-11-29

9.  Risk factors of lymph edema in breast cancer patients.

Authors:  Haghighat Shahpar; Akbari Atieh; Ansari Maryam; Homaei Shandiz Fatemeh; Najafi Massoome; Ebrahimi Mandana; Yunesian Masud; Mirzaei Hamid Reza; Akbari Mohammad Esmaeil
Journal:  Int J Breast Cancer       Date:  2013-06-05

10.  Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab.

Authors:  Marco Invernizzi; Anna Michelotti; Marianna Noale; Gianluca Lopez; Letterio Runza; Massimo Giroda; Luca Despini; Concetta Blundo; Stefania Maggi; Donatella Gambini; Nicola Fusco
Journal:  J Clin Med       Date:  2019-01-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.